Tesla Won’t Hit Quarterly Forecast: Analyst
KeyBanc Capital Markets' analyst has maintained his Sector Weight rating on Tesla stock but warns that Model 3 sales will be light in the fourth quarter.
KeyBanc Capital Markets' analyst has maintained his Sector Weight rating on Tesla stock but warns that Model 3 sales will be light in the fourth quarter.
Premier luxury restaurant and theater brand iPic Entertainment intends to price more than 2 million shares to end up with an initial public offering valued up to $40 million.
The Conference Board has released its December reading on consumer confidence. After coming in with a rather strong reading in November, the index fell in December.
Practically any mention of blockchain being integrated into any business has been cheered by investors, and for Nova Lifestyle it seems no different.
Global sales at Ford are on track to be slightly lower than 2016 sales with one month of sales remaining in 2017.
The top analyst upgrades, downgrades and other research calls from Wednesday include Callaway Golf, Capital One, Sarepta Therapeutics, Tesla, UnitedHealth and Wayfair.
Retail sales of seasonal clothing took a hit in the week before Christmas as warm weather covered most of the United States until the end of the week.
These two biotech and two tech stocks not only have big upside potential, but they are priced right for investors looking for good entry points.
What has been hard to ignore is that Wall Street is now calling for energy stocks to return to being a positive factor ahead rather than a drag as was seen throughout much of…
Elon Musk said that a Tesla pickup would be full-sized version, which means it will compete with the best-selling vehicle in the country.
While it is too early to tell, discretionary income in many areas around the nation could be curtailed and undermine consumer spending.
Oil prices have risen sharply, Uber dumped its auto-leasing operation, Tesla may get into the pickup business, and more important headlines.
24/7 Wall St. has chosen its list of the “Worst CEOs In America” for 2017. All the executives on this list have done serious damage to the companies they lead. In some cases it…
Ahead of the California legalization efforts, a U.S.-listed marijuana-focused exchange traded fund has quietly begun trading.
PPL Corp., Iconix, Pacific Biosciences, and Zosano Pharma all posted new 52-week lows on Tuesday.